Related Experiment Video
Updated: Mar 24, 2026

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
Published on: July 14, 2023
Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction
Victoria Karetnikova1, Anastasia Osokina1, Olga Gruzdeva2
1Federal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases", 6 Sosnovy Boulevard, Kemerovo 650002, Russia; Federal State Budget Educational Institution of Higher Professional Education "Kemerovo State Medical Academy of the Ministry of Health of the Russian Federation", 22a Voroshilov Street, Kemerovo 650029, Russia.
Insights
Serum galectin levels and renal dysfunction predict poor prognosis in ST-elevated myocardial infarction (STEMI) patients one year post-event. Elevated galectin correlates with early post-infarction angina, indicating higher risk.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- ST-elevated myocardial infarction (STEMI) poses significant risks for both cardiac and renal health.
- Renal dysfunction is an established predictor of adverse outcomes following STEMI.
- The role of specific biomarkers like galectin in predicting prognosis in STEMI patients with renal dysfunction requires further elucidation.
Purpose of the Study:
- To investigate the association between serum galectin levels and renal dysfunction.
- To evaluate the predictive value of galectin and renal function for in-hospital and one-year prognosis after STEMI.
- To explore the correlation between elevated galectin levels and early postinfarction angina.
Main Methods:
- Patients with STEMI were stratified into two groups based on cystatin C-estimated glomerular filtration rate (GFR) on day 12: normal GFR (≥60 mL/min/1.73 m²) and renal dysfunction (RD) (<60 mL/min/1.73 m²).
- GFR was also estimated using the CKD-EPI equation.
- Serum galectin levels were measured, and a cut-off value of 17.8 ng/mL was used.
Main Results:
- A decrease in CKD-EPI estimated GFR was more frequent in patients with RD (41.9%) compared to those with normal renal function (21.3%).
- Elevated galectin levels (>17.8 ng/mL) were observed in 50.6% of patients with RD versus 32% in the normal GFR group.
- Both RD and elevated galectin levels independently predicted an adverse one-year prognosis in STEMI patients.
- Elevated galectin levels showed a direct correlation with early postinfarction angina.
Conclusions:
- Renal dysfunction and elevated serum galectin levels are independent predictors of adverse prognosis one year after STEMI.
- Galectin may serve as a valuable biomarker for risk stratification in STEMI patients, particularly those with compromised renal function.
- The findings highlight the intricate relationship between cardiac events, renal health, and systemic inflammation indicated by galectin.
Abstract:
This study aimed to evaluate the association between serum galectin levels and renal dysfunction in relation to in-hospital prognosis and unfavorable prognosis 1 year after ST-elevated myocardial infarction (STEMI). Patients were assigned to two groups according to the cystatin C-based estimate of GFR on day 12 after STEMI: (1) STEMI patients with normal renal function (GFR based on cystatin C levels = 60 mL/min/1.73 m(2)) and (2) those with renal dysfunction (RD) (GFR based on cystatin C levels <60 mL/min/1.73 m(2)). A decrease in GFR estimated from the CKD-EPI equation on day 12 was more frequently found in patients with a reduced GFR based on cystatin C levels (41.9%) compared with those without RD (21.3%). Galectin levels exceeded the cut-off value (17.8 ng/mL) in 50.6% of cases in the group with GFR <60 mL/min/1.73 m(2) and in 32% of cases in the group with a normal GFR. The presence of RD and elevated galectin levels >17.8 ng/mL on day 12 after MI are independent predictors of an adverse prognosis at 1 year in STEMI patients. Elevated galectin levels are directly correlated with the presence of early postinfarction angina.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Serum Studies: Renal Function Tests

